Democratic Republic of Congo vs Papua New Guinea: Antiretroviral therapy coverage for PMTCT
Democratic Republic of Congo
32.0%
in 2024
Papua New Guinea
28.0%
in 2024
Democratic Republic of Congo rank
75th
Papua New Guinea rank
78th
Antiretroviral therapy coverage for PMTCT over time
- Democratic Republic of Congo
- Papua New Guinea
How they compare
Democratic Republic of Congo currently reports 32.0% against 28.0% in Papua New Guinea, a difference of 4.0%.
That makes Democratic Republic of Congo's figure about 1.1 times Papua New Guinea's.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Papua New Guinea ahead.
Democratic Republic of Congo ranks 75th and Papua New Guinea ranks 78th of 84 countries.
Democratic Republic of Congo has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Democratic Republic of Congo | Papua New Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.8% | 0.7% | 4.1% | Democratic Republic of Congo |
| 2010s | 34.5% | 10.9% | 23.6% | Democratic Republic of Congo |
| 2020s | 37.2% | 20.6% | 16.6% | Democratic Republic of Congo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Democratic Republic of Congo or Papua New Guinea?
- Democratic Republic of Congo, at 32.0% against 28.0% in Papua New Guinea as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Democratic Republic of Congo and Papua New Guinea?
- 4.0%, with Democratic Republic of Congo ahead.
- How many years of comparable data are there for Democratic Republic of Congo and Papua New Guinea?
- 25 years are reported by both, from 2000 to 2024.
- How do Democratic Republic of Congo and Papua New Guinea rank globally for antiretroviral therapy coverage for pmtct?
- Democratic Republic of Congo ranks 75th and Papua New Guinea ranks 78th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).